Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Further studies on allopurinol therapy and human cataractogenesis

Journal Article · · Am. J. Ophthalmol.; (United States)

We examined 11 cataractous lenses (or aspirated lens matter from extracapsular extractions) from patients ranging in age from 55 to 84 years who used allopurinol on a long-term basis (more than two years). Phosphorescence analyses demonstrated the characteristic allopurinol triplet in these lenses. When we analyzed normal lenses from patients taking allopurinol in a similar manner we found no evidence of allopurinol photobinding. These data indicated that allopurinol has a cataractogenic action only in patients in whom the drug has become photobound within the lens. Long-term allopurinol therapy does not necessarily cause or enhance cataracts in all patients. There may be a relationship between ultraviolet radiation exposure and circulating allopurinol levels (and perhaps renal function) in the genesis of photosensitized allopurinol cataracts.

Research Organization:
Emory Univ., Atlanta, GA
OSTI ID:
6747742
Journal Information:
Am. J. Ophthalmol.; (United States), Journal Name: Am. J. Ophthalmol.; (United States) Vol. 97:2; ISSN AJOPA
Country of Publication:
United States
Language:
English

Similar Records

Allopurinol therapy and cataractogenesis in humans
Journal Article · Sun Aug 01 00:00:00 EDT 1982 · Am. J. Ophthalmol.; (United States) · OSTI ID:6638206

Psoralen--long-wave ultraviolet therapy and human cataractogenesis
Journal Article · Tue Nov 30 23:00:00 EST 1982 · Invest. Ophthalmol. Visual Sci.; (United States) · OSTI ID:6239935

RADIATION CATARACTOGENESIS
Journal Article · Mon Oct 01 00:00:00 EDT 1962 · New York State Journal of Medicine (U.S.) · OSTI ID:4755689